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Abnormal apoptotic mechanisms are associated with disease
pathogenesis. Because the asthmatic bronchial epithelium is
characteristically damaged with loss of columnar epithelial
cells, we postulated that this is due to unscheduled apoptosis.
Using an antibody directed toward the caspase cleavage prod-
uct of poly(ADP-ribose) polymerase, immunohistochemistry
applied to endobronchial biopsies showed higher levels of stain-
ing in the bronchial epithelium of subjects with asthma as
compared with normal control subjects (% epithelial staining
[median (range) 
 

 
 10.5 (1.4–24.5) versus 0.4 (0.0–9.7)]; 
 
P
 
 
 

 
0.001). Because we were unable to determine whether this
 
difference was due to ongoing inflammation 
 
in vivo
 
, cultures
of normal and asthmatic bronchial epithelial cells were used
 
to study apoptosis 
 
in vitro
 
. In complete growth medium, these
cells showed no difference in their rate of proliferation or via-
bility. However, cells from subjects with asthma were more
 
susceptible to the apoptotic effects of H
 
2
 
O
 
2
 
 than cells from
normal control subjects (% apoptotic cells 
 

 
 32.2 [8.8–54.9]
versus 14.3 [6.4–24.7]; 
 
P
 
 
 

 
 0.05), even though both were simi-
larly affected by treatment with actinomycin D. These data in-
dicate that the susceptibility of asthmatic bronchial epithe-
lium to oxidants is greater than normal. This susceptibility
may contribute to the rising trends in asthma associated with
air pollution and diets low in antioxidants.
 
There has been a marked increase in prevalence of asthma
over the last 30 yr. This is most likely due to changes in the
environment acting on a susceptible genotype both in the
induction and worsening of established disease (1). This pro-
posal is supported by epidemiologic studies identifying
multiple interacting risk factors, including inhaled pollut-
ants (e.g., environmental tobacco smoke [ETS], particulate
matter [PM
 
10
 
], oxides of nitrogen, and ozone [O
 
3
 
]), re-
duced exposure to bacterial products, and repeated respira-
tory virus exposure (2). Because these agents impact on
the surface of the airway, their interaction with the bron-
chial epithelium may reflect the activity of those suscepti-
bility genes that operate locally in the airways to lead to al-
tered inflammation, injury, and repair responses.
The fully differentiated normal bronchial epithelium acts
as a physical barrier to protect the internal milieu of the
conducting airways by secreting mucus and cytoprotective
molecules, displaying ciliary activity, and interacting with
cells of the innate and adaptive immune systems. In asthma,
the bronchial epithelium shows evidence of damage with
loss of columnar cells from their basal cell attachments (3,
4). Although it has been suggested that epithelial damage
observed in asthmatic biopsies obtained by fiberoptic bron-
choscopy may be artifactual (5), the enhanced expression
of the epidermal growth factor receptor (EGFR, HER1,
c-erbB1) (6) is evidence that injury has occurred 
 
in vivo
 
.
One consequence of epithelial injury in asthma is that the
epithelium becomes an important source of autacoid me-
diators, chemokines, and growth factors that contribute to
ongoing inflammation and myofibroblast activation, lead-
ing to tissue remodeling (7).
The extent of epithelial disruption seen in asthma is not
observed in other inflammatory diseases such as cystic fi-
brosis (CF) and chronic obstructive pulmonary disease
(COPD), even though these conditions are closely associ-
ated with microbial infections and high concentrations of
irritant tobacco smoke, respectively. Although these dif-
ferences may reflect the quality of inflammation, this can-
not be the sole explanation, as airway eosinophilia can be
observed in the absence of asthma or bronchial hyperreac-
tivity (BHR) (8) and, as with COPD and CF, neutrophils
may dominate inflammation in severe asthma. This raises
the possibility that the extent of epithelial damage in asthma
is due to increased susceptibility to a damaging agent and/or
an inadequate repair response.
Apoptosis is a mechanism that is fundamental to tissue
homeostasis. Failure to initiate apoptosis after sustaining
severe DNA damage is known to contribute to the devel-
opment of neoplasia (9), whereas unscheduled apoptosis con-
tributes to neurodegenerative disorders such as Alzheimers
disease (10) and autoimmune disease including Hashi-
moto’s thyroiditis. Apoptosis has been observed in alveolar
epithelial cells in pulmonary fibrosis (11) and in kerati-
nocytes in atopic dermatitis (12), a condition that predis-
poses to severe asthma. Although epithelial apoptosis is
increased in fatal asthma (13), it has been reported that
there is no difference between the number of TUNEL-
positive, late apoptotic cells in epithelium of bronchial bi-
opsies from normal subjects versus those with asthma (14).
Because large numbers of asthmatic bronchial epithelial
cells are characteristically shed into the airways lining fluid
(3), we considered the possibility that late apoptotic cells
are rapidly lost from biopsies before or during the bron-
choscopy procedure. Therefore, we have analyzed bron-
chial epithelium for evidence of early apoptosis by exam-
ining the presence of p85, a peptide fragment which is
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generated by cleavage of poly(ADP-ribose) polymerase
(PARP) by caspase-3 (15), a cysteine–aspartate protease
that is involved in initiation of the apoptotic process. Fur-
thermore, to determine whether there is a fundamental
difference in epithelial susceptibility in asthma, we have
established primary cultures of bronchial epithelial cells
from normal subjects and subjects with asthma to compare
apoptotic responses under identical conditions 
 
in vitro
 
.
 
Materials and Methods
 
Subjects
 
Anonymous archival glycol methacrylate (GMA) embedded
bronchial biopsies, taken from 9 normal subjects and 13 subjects
with asthma were used for the immunohistochemical study. The
asthmatic group consisted of six males and seven females, with a
mean (
 

 
 SD) age of 37.0 
 

 
 15.2 yr (range, 20–67), and a mean
FEV
 
1
 
 of 68% predicted (range, 39.3–106%). The normal group
was comprised of four males and five females, with a mean age of
20.9 
 

 
 1.3 yr (range, 20–22) and a mean FEV
 
1
 
 of 104 
 

 
 7.5% of
predicted. The subjects with asthma were classified according to
the Global Strategy for Asthma Management and Prevention
(GINA) guidelines (16), with those subjects with mild asthma (
 
n
 
 
 

 
7) receiving only the 
 

 
2
 
-agonist albuterol and those with severe
asthma (
 
n
 
 
 

 
 6) being treated with a regular mean inhaled steroid
dose of 950 
 

 
g/d (range, 200–2,000) and a regular oral corticos-
teroid at a mean of 36 mg/d (range, 10–60).
For bronchial brushing, nine nonatopic, nonasthmatic control
subjects (five male) with a mean (
 

 
 SD) age of 22.7 
 

 
 4.9 yr
(range, 19–33); and 11 atopic asthmatic subjects (10 male) with a
mean (
 

 
 SD) age of 26.0 
 

 
 7.1 yr (range, 19–37) were character-
ized according to symptoms, pulmonary function, and medica-
tion. The control group had a mean FEV
 
1
 
 of 98% predicted
(range, 78–110) and a PC
 
20
 
 histamine 
 

 
 8 mg/ml, whereas the
atopic asthmatic group had a mean FEV
 
1
 
 of 90% predicted
(range, 78–100) and a PC
 
20
 
 histamine of 2.7 (geometric mean)
(range, 0.3–16) mg/ml. Subjects with mild asthma (
 
n
 
 
 

 
 9) were
receiving albuterol only, whereas the two subjects with moder-
ately severe asthma were on a mean inhaled steroid dose of 1,000
 

 
g/d. These two subjects withheld this medication for a minimum
of 1 wk before bronchoscopy. All subjects were nonsmokers and
had been free from respiratory tract infections for a minimum of
4 wk before inclusion in the study. Written informed consent was
obtained from all volunteers before participation, and ethical
approval was obtained from the Joint Ethics Committee of
Southampton University Hospital Trust.
 
Fiberoptic Bronchoscopy
 
Epithelial brushings were obtained by bronchoscopy using a fi-
beroptic bronchoscope (FB-20D; Olympus, Tokyo, Japan) in ac-
cordance with standard published guidelines (17). Bronchial
epithelial cells were obtained using a standard sterile single-
sheathed nylon cytology brush (BC 9C-26101; Olympus). On av-
erage, five to six consecutive brushings were sampled from the
bronchial mucosa of the second and third generation bronchi,
and for large scale culture a maximum of 12–14 brushings were
performed. Cells were harvested into 5 ml sterile phosphate-buff-
ered saline (PBS) after each brushing. At the completion of the
procedure, 5 ml RPMI with 10% fetal bovine serum (FBS) was
added and the sample centrifuged at 150 
 
	
 
 
 
g
 
 for 5 min to harvest
the cells. Epithelial cell purity was assessed by performing differ-
ential cell counts of the harvested cell suspension.
To obtain luminal cells, bronchoalveolar lavage (BAL) was
performed according to standard protocols (17). Cells were har-
vested by centrifugation and then processed for cytochemical
analysis by cytocentrifugation. Differential cell counts confirmed
the presence of epithelial cells before immunostaining for p85
PARP was undertaken.
 
Biopsy Processing and Immunohistochemistry
 
Processing of biopsies into GMA and the immunohistochemical
method applied to this material have been described in detail (18)
Briefly, 2-
 

 
m sections were processed for immunohistochemistry
using the streptavidin–biotin–peroxidase detection system. The
sections were incubated with either a rabbit anti-p85 PARP anti-
body (Promega, Southampton, UK) at 1:250 or a monoclonal an-
tibody (mAb) to cytokeratin 18 (CK18; Sigma Chemicals, Poole,
Dorset, UK) at 1:1,000 overnight at 4
 


 
C or room temperature, re-
spectively. In each case, negative controls comprising matched
immunoglobulins and buffer alone were included. After washing,
anti-rabbit or anti-mouse biotinylated IgG Fab fragments at
1:600 or 1:300, respectively (Dako Ltd, Wycombe, UK) were ap-
plied to the sections for 2 h. This was followed by a 2-h incuba-
tion with streptavidin–biotin horseradish–peroxidase complex at
1:200 (Dako Ltd, Wycombe, UK) before visualization with ami-
noethylcarbazine as chromogen. Sections were counterstained
with Mayer’s hematoxylin and mounted in DPX.
Epithelial expression of immunoreactive p85 PARP in GMA
sections was quantified by computer-assisted image analysis (Col-
orvision 1.7.6; Improvision, Coventry, UK). For each biopsy spec-
imen, the entire intact epithelium in two nonserial sections was
systematically assessed based on red, blue, and green (RGB) color
balance. At the beginning of each session, the image analysis sys-
tem was standardized using the same section of bronchial mucosa
stained for p85 PARP, to ensure reproducibility of analysis (6).
Each slide was coded and measurement of p85 PARP expression
was performed by an observer who was unaware of the clinical
group from which the biopsy specimen was derived.
 
Analysis of PARP Cleavage by SDS-PAGE and
Western Blotting
 
H292 bronchial epithelial cells were seeded into 24-well dishes in
RPMI 1640/10% fetal calf serum and grown to 70–80% conflu-
ence. After serum starvation for 24 h, the cells were treated in se-
rum-free medium with or without 10 ng/ml tumor necrosis factor
(TNF)-
 

 
 in the absence or presence of H
 
2
 
O
 
2
 
 (50–400 
 

 
M) for 1,
3, or 4 h. At the end of each time point, cells were lysed into SDS
sample buffer and analyzed by SDS-PAGE and Western blotting
with p85 PARP antibody and a pan PARP antibody, using previ-
ously described protocols (6).
 
Epithelial Cultures
 
Primary cultures were established by seeding freshly brushed
bronchial epithelial cells into culture dishes containing 3 ml of se-
rum-free hormonally-supplemented Bronchial Epithelium Growth
Medium (BEGM; Clonetics, San Diego, CA) containing with 50 U/ml
penicillin and 50 
 

 
g/ml streptomycin. When confluent, the cells
were passaged (p1) using trypsin and were allowed to further
expand until used for experimentation at passage 2 or 3; control
experiments confirmed that there was no significant difference
between the responses of the cells at p2 or p3. Viability was as-
sessed by exclusion of trypan blue dye and the epithelial nature
of cells assessed by immunocytochemistry using a pan-CK anti-
body and antibodies specific for CK13 and CK18.
 
Analysis of Apoptosis by Flow Cytometry
 
Apoptosis was measured according to the technique of Vermes
and coworkers (19), in which binding of annexinV (AxV) was
used to detect phosphatidylserine, which is externalized on the
outer leaflet of the plasma membrane of apoptotic cells. Briefly,
primary bronchial epithelial cells (5 
 
	
 
 10
 
4
 
/well) were grow to 80–
90% confluence in 24-well plates (Nunc, Fisher Scientific, Lough-
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borough, UK). The BEGM medium was then replaced with basal
medium (BEBM; Clonetics) containing insulin, transferrin and
sodium selenite supplement (Sigma), and the cells rendered qui-
escent for 24 h before exposure to H
 
2
 
O
 
2
 
, actinomycin D or TNF-
 

 
(Peprotech, London, UK) for up to 24 h as detailed in Results.
Adherent cells were harvested with trypsin in Ca
 
2
 

 
 and Mg
 
2
 

 
-
free Hanks’ balanced salt solution and combined with nonadher-
ent cells for analysis. After washing twice in cold PBS, the cells
were resuspended at a density of 1 
 
	
 
 10
 
5
 
 cells/100 
 

 
l of binding
buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl
 
2
 
) in 5
ml propylene FACS tubes. AxV-FITC (1 
 

 
g/ml) and propidium
iodide (PI) (2.5 
 

 
g/ml) were added to the tubes and incubated in
the dark for 15 min, after which 400 
 

 
l of cold binding buffer
were added and cells analyzed using a FACScan flow cytometer
(Becton and Dickinson, Oxford, UK). In the case of H292 cells,
PI was replaced with 7-aminoactinomycin D (7-AAD). Control
tubes lacking AxV-FITC, PI, or both were included for the acqui-
sition. Analysis of dotplots of FL1(AxV-FITC) versus FL2 (PI)
was performed using WinMDI 2.8. The degree of apoptosis was
expressed as the number of AxV
 

 
/PI
 

 
 cells shown as a percent-
age of total cells.
 
Cytokine Measurement by Enzyme-Linked
Immunosorbent Assay
 
Release of IL-8 into culture supernatants of bronchial epithelial
cells was measured using enzyme-linked immunosorbent assay
kits for IL-8 according to the manufacturer’s instructions (R&D
Systems, Abingdon, UK).
 
Statistical Analysis
 
Data was analyzed by the Mann–Whitney U test or the Wilcoxon
rank-sum test for paired samples. A p value 
 

 
 0.05 was consid-
ered significant.
 
Results
 
Detection of Apoptosis in Bronchial Biopsies of Normal 
Subjects and Subjects with Asthma
 
To detect evidence of early apoptosis in bronchial biop-
sies, immunohistochemistical analysis was undertaken using
an antibody specific for p85, the caspase cleavage product of
PARP. The specificity of this antibody was demonstrated
using H292 bronchial epithelial cells exposed to H
 
2
 
O
 
2
 
 and
TNF-
 

 
, which together caused an increase in apoptosis as
measured by FACS analysis (%AxV
 

 
/7AAD
 

 
 cells 
 

 
18.4 
 

 
 8.4 versus 2.9 
 

 
 0.5; 
 
P
 
 
 

 
 0.01). As shown in Figure
1, exposure of H292 cells to increasing doses of H
 
2
 
O
 
2
 
 in
the presence of TNF-
 

 
 caused a dose-dependent increase
in PARP cleavage. By comparison with a pan p85 anti-
body, which recognized full-length and cleaved PARP, the
p85 antibody recognized only cleaved PARP.
When the p85-specific antibody was applied to bron-
chial biopsies, staining for p85 PARP in either the bron-
chial epithelium or submucosa of normal subjects was
minimal and tended to be slightly higher than that seen in
tissue sections stained with an irrelevant control immuno-
globulin (Figure 2A versus 2C). In contrast, using biopsies
from subjects with asthma of varying severity, there was
marked staining for p85 PARP in the epithelium (Figure
2B), as well as in a limited number of inflammatory cells in
the submucosa (Figure 2D). In the asthmatic bronchial ep-
ithelium, staining was frequently patchy (Figure 2E) and
usually occurred in columnar cells showing both a nuclear
 
and cytoplasmic distribution. Furthermore, the majority of
epithelial cells present in asthmatic BAL fluid also showed
strong immunostaining for p85 PARP (Figures 2F–2H).
Quantitation of staining using computerized image analy-
sis confirmed that epithelial p85 PARP staining was signif-
icantly increased in the asthmatic biopsies when compared
with those from normal control subjects (% epithelial
staining [median (range) 
 

 
 10.5 (1.4–24.5) versus 0.4 (0.0–
9.7)]; 
 
P
 
 
 

 
 0.001) (Figure 3). As a control for the analysis of
p85 PARP staining, we also stained cells with an antibody
to CK18. In this case, staining was uniform within the epi-
thelium and there was no significant difference in the ex-
tent of staining observed in asthmatic (% epithelial stain-
ing median [range] 
 

 
 42.6 [17.3–49.8], 
 
n
 
 
 

 
 13) and normal
(36.9 [30.2–53.5], 
 
n
 
 
 

 
 9; 
 
P
 
 
 

 
 0.05) bronchial epithelium.
 
Analysis of Apoptosis in Bronchial Epithelial Cells 
 
In Vitro
 
Although immunochemical analysis suggested that there
was increased apoptosis in the asthmatic bronchial epithe-
lium, we could not distinguish whether this was a conse-
quence of the ongoing inflammation in the bronchial tis-
sue. Therefore, we established primary cultures of normal
and asthmatic bronchial epithelial cells to measure apop-
tosis under controlled conditions 
 
in vitro.
 
 However, be-
cause there was no information on the properties of nor-
mal and asthmatic epithelial cell cultures established from
bronchial brushings, it was first necessary to characterize
the primary cultures to ensure that any differences in apo-
ptotic behavior were not a consequence of differing viabil-
ity or growth patterns.
 
Characterization of Bronchial Brushings and Epithelial
Cultures.  
 
Cytologic analyses of samples of bronchial brush-
ings showed that the yield of epithelial cells obtained by
brushing either normal or asthmatic airways was 
 

 
 90%,
with the remaining cells being neutrophils or eosinophils.
By immunocytochemistry, the majority of the epithelial
Figure 1. Detection of PARP Cleavage in Bronchial Epithelial
Cells. H292 bronchial epithelial cells were exposed in SFM alone
or with 10 ng/ml TNF- in the absence or presence of H2O2 (50–
400 M) for 1, 3, and 4 h and the cell lysates analyzed by SDS
PAGE and Western blotting. A shows lysates from cells treated
in the absence () or presence () of 10 ng/ml TNF- and 300
M H2O2 for 4 h and probed with a pan PARP antibody or the
p85 PARP antibody. B shows the time and dose dependence of
the appearance of p85 PARP immunoreactivity following expo-
sure to pro-apoptotic stimuli. Data are representative of three in-
dependent observations.
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cells were of a columnar phenotype staining positively for
CK18 and negatively for CK13; in each case, a small per-
centage (
 

 
 10%) of the cells were of a basal cell pheno-
type expressing both CK18 and CK13. Primary epithelial
cultures could be established in BEGM, with a frequency
of 9/10 and 11/16 for normal and asthmatic epithelial cells,
respectively. Failure to establish a culture invariably re-
sulted from mycotic infection rather than from inability of
the cells to proliferate. Infection usually occurred if brush-
ings were heavily contaminated with blood, hence extreme
care was taken during the bronchoscopy procedure to min-
imize trauma to the mucosal surface. No gross morphologic
differences were evident between the normal and asth-
matic cultures and no difference was observed in their mean
generation time (Figure 4), with cell yields from 5–6 brush-
ings being in the range (1.5–4.0 
 
	 106) and (2.0–4.5 	 106)
at the end of p1 and viabilities of 98% and 95% for normal
and asthmatic cultures, respectively. Cultures usually ex-
panded through p2 and p3, but thereafter became quies-
cent. For large-scale cultures, up to a maximum of 12–14
brushings have been collected, and this was well tolerated
by most patients; these more extensive brushings pro-
duced a corresponding increase in cell yield. Immunocy-
tochemical analysis of the monolayer cultures showed that
all cells were CK18 and CK13, suggesting that these pro-
liferating cells resembled basal cells (data not shown).
Susceptibility to oxidant-induced apoptosis.  Having es-
tablished that the in vitro growth properties of the epithe-
lial cultures were similar, they were rendered quiescent for
24 h to compare their sensitivity to oxidant stress as deter-
mined by induction of apoptosis. Initial experiments con-
firmed that increasing concentrations of H2O2 over the
range 50–500 M caused a dose-dependent increase in ap-
optotic (i.e., AxV/PI) cells; however, as the dose in-
creased, there was a sharp increase in the number of ne-
Figure 2. Bronchial biopsies from normal
subjects and subjects with asthma were
stained by immunohistochemistry for the
presence of p85 PARP. The plates show
typical epithelial staining patterns observed
in normal subjects (A) or subjects with
asthma (B). C shows staining obtained with
control rabbit immunoglobulin. D shows
detail of p85 PARP staining in the submu-
cosa where the arrows indicate p85 PARP
immunoreactivity in a subset of the sub-
mucosal cells. E shows the patchy nature
of the p85 staining in the asthmatic bron-
chial epithelium. F–H show three fields
from cytopreparations of BAL cells dem-
onstrating p85 PARP-positive staining of
shed columnar epithelial cells and a field
from a matched negative control cytoprep-
aration (I). Bar  20 m.
Figure 3. Quantitative analysis of p85 PARP staining in normal
and asthmatic bronchial biopsies. Data were analyzed using Mann–
Whitney U test.
Figure 4. Characterization of the growth properties of normal
and asthmatic bronchial epithelial cultures. The mean generation
time of normal (circles) and asthmatic (triangles) epithelial cul-
tures was calculated from cell yield en passage.
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crotic (ie. AxV/PI) cells (data not shown), therefore a
working dose of 300 M was selected for subsequent stud-
ies. Using these conditions, the asthmatic epithelial cell cul-
tures were found to be significantly more sensitive to H2O2,
with the percentage of AxV/PI cells (median [range])
being 32.2% (8.8–54.9%) in the subjects with asthma and
14.3% (6.4–24.7%) in the normal subjects (P  0.05) (Fig-
ure 5A). In contrast, there was no significant difference in
the response of asthmatic or normal epithelial cell cultures
to the pro-apoptotic effects of the DNA and RNA synthe-
sis inhibitor, Actinomycin D (34.4 [13.5–44.2] versus 24.1
[7.1–54.6]; P  0.34).
Neither normal nor asthmatic epithelial cultures showed
any increase in apoptosis in the presence of TNF- (Figure
5B), and no additional effect of TNF- was observed over
that obtained with H2O2 alone. This was not due to lack of
TNF- receptors, as IL-8 release was increased by TNF-
(IL-8 release [median (range)] in the absence and presence
of TNF- was 2.5 [0.1–8.2] and 14.3 [3.2–103.6] ng/106 cells
[P  0.01] for normal epithelial cultures and 2.5 [0.1–14.5]
versus 16.2 [1.8–49.6] ng/106 cells [P  0.01] for asthmatic
cultures).
Discussion
Disruption of the bronchial epithelium with shedding of
the columnar cells as Creola bodies is a characteristic find-
ing in asthma (3), correlating both with BHR (4) and epi-
thelial permeability (20). Even though there is substantial
evidence of epithelial damage, it is surprising that a previ-
ous study failed to reveal any difference in the levels of
apoptosis in asthmatic bronchial epithelium using the
TUNEL technique (14), which identifies cells undergoing
DNA fragmentation at a relatively late stage of apoptosis.
In contrast with that report, in the present study we have
found a significant increase in early apoptotic cells in asth-
matic bronchial epithelium through the use of an antibody
that detects PARP cleavage by caspase-3. Our findings are
also consistent with a recent report by Benayoun and co-
workers who found that the presence of the active, cleaved
form of caspase-3 was increased in the bronchial epithe-
lium of untreated subjects with asthma when compared
with nonasthmatic control subjects (21). Close examina-
tion of the pattern of p85 staining in the asthmatic biopsies
revealed patchy areas of strong immunoreactivity, whereas
areas of adjacent epithelium were only weakly stained.
The appearance of the epithelial staining suggested that
those areas of positive immunoreactivity might be des-
tined to be shed as Creola bodies. This suggestion is sup-
ported by our finding that detached epithelial cells found
in BAL fluid also stained positively for p85 PARP. Be-
cause caspases cleave a variety of structural proteins such
as cytokeratin (22), we postulate that disruption of the cy-
toskeleton leads loss of apoptotic cells from the epithelium
before DNA fragmentation occurs. Consistent with this
proposal, we found that pro-apoptotic stimuli caused de-
tachment of bronchial epithelial cells from their culture
dishes from  4 h of treatment (data not shown). Simi-
larly, caspase activation and initiation of apoptosis has
been observed in bronchial epithelial cells following de-
tachment caused by disruption of the actin cytoskeleton
(23). These effects on cell adhesion may explain the dis-
crepancy between the current study and the previous
study that used TUNEL.
In addition to epithelial staining, there was also an in-
crease in apoptotic cells in the submucosa which could be
clearly distinguished from p85 PARP negative cells; how-
ever, we have not attempted to characterize the nature of
these cells. The apoptosis did not appear to be due to the
use of corticosteroids, which are known to promote eosi-
nophil apoptosis (24), because apoptosis was evident in
submucosal cells of patients using bronchodilators only.
Because the use of TUNEL to demonstrate the occur-
rence of apoptotic eosinophils in airway tissue is conten-
tious (25), further studies using double staining to identify
eosinophils and p85 PARP and other markers of caspase
activation are warranted.
As we were unable to differentiate whether the in-
creased level of epithelial apoptosis in asthmatic biopsies
Figure 5. The susceptibility of normal and asthmatic bronchial
epithelial cells to oxidant induced apoptosis. Primary cultures of
quiescent normal (circles) (n  9) or asthmatic (triangles and dia-
monds denote subjects with mild and moderate asthma, respec-
tively) (n  11) bronchial epithelial cells were untreated or ex-
posed to (A) 300 M H2O2, or to 10 g/ml actinomycin D or (B)
TNF- (10 ng/ml) in the absence or presence of 300 M H2O2 for
24 h. Cells were then harvested and apoptosis was measured by
FACS analysis using AxV and PI. The figure shows % early apo-
ptotic cells (AxV/PI) where each data point is a mean of dupli-
cate observations obtained for each individual donor.
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was merely a consequence of ongoing inflammation, we
extended our studies to analyze apoptosis in vitro using
primary cultures established from bronchial brushings. The
respiratory epithelium is in direct contact with the envi-
ronment and is a major target for oxidative injury from in-
haled oxidants (O3, ETS, nitrogen and sulfur dioxides,
PM10). Because inflammatory cells such as eosinophils and
neutrophils also generate endogenous oxidants together
with TNF-, a known pro-apoptotic stimulus (26), we
studied a model of oxidant injury with or without TNF-.
It has been estimated that local concentrations of around
100 M H2O2 can easily be generated by activated granu-
locytes (27); therefore, the amounts of oxidant used in the
present study might be expected to fall within physiologic
or pathophysiologic ranges. The finding that asthmatic
bronchial epithelial cells were more susceptible to oxi-
dant-induced apoptosis in vitro is consistent with our ob-
servation of increased caspase activation in vivo. As our in
vitro studies were performed with monolayer cultures of
undifferentiated cells, this suggests that the susceptibility
of asthmatic bronchial epithelial cells to oxidants is not de-
pendent on their differentiation state; whether this is due
to an inherited or acquired defect remains to be deter-
mined. Significantly, neither normal nor asthmatic bron-
chial epithelial cells were caused to undergo apoptosis by
TNF-. Because TNF- caused IL-8 release, our data indi-
cate that TNF- has proinflammatory effects on normal
and asthmatic epithelium which are distinct from survival
or apoptotic mechanisms.
A number of studies have indicated roles for reactive
oxygen (ROS) and reactive nitrogen (RNS) species in the
pathology of asthma both in terms of increased burden and
decreased antioxidant defenses (28). Airway responses
have been shown to correlate with oxidant generation by
eosinophils after antigen challenge in vivo (29) and neu-
trophil superoxide generation correlates with BHR (30).
Airway lining fluid from subjects with asthma has a lower
antioxidant capacity than fluid from normal subjects (31),
and intracellular Cu,Zn superoxide dismutase (Cu,Zn-
SOD) activity is decreased in asthma, but could be nor-
malized upon corticosteroid treatment (32). In a separate
study, reduced SOD activity was found in brushed bron-
chial epithelial cells from patients with asthma and was
shown to strongly correlate with BHR (33). Although
these studies have demonstrated altered oxidant defenses
in asthma, most appear to be a consequence of the inflam-
matory process. In contrast, in the present study, the pri-
mary epithelial cultures were taken through several gener-
ations in vitro to allow recovery from any changes that had
occurred in vivo as consequence of airway inflammation.
Thus, our finding that asthmatic bronchial epithelial cells
retained a higher susceptibility to oxidant injury suggests a
different underlying cause than in the previous studies.
This susceptibility may explain the extent of epithelial fra-
gility in asthma as compared with other inflammatory con-
ditions in the airways.
In asthma, inflammatory products have been proposed
to cause tissue injury and cytokine release, leading to a
self-perpetuating cycle of injury and inflammation. How-
ever, this does not explain how the appropriate microenvi-
ronment is created in the airway to establish and maintain
this inflammation, nor does it account for the increased
sensitivity of subjects with asthma to components of the
inhaled environment. Epidemiologic studies have demon-
strated important links between air pollutants such as die-
sel exhaust particles (DEP), O3, and ETS in asthma patho-
genesis and exacerbation (34), and others have shown a
strong link between diets low in antioxidants and asthma
(35). Our studies help explain these phenomena because
the sensitivity of asthmatic epithelial cells to oxidant-in-
duced apoptosis may be a key triggering mechanism that
facilitates the induction and establishment of chronic in-
flammatory responses. This proposal is consistent with a
previous report in which asthmatic bronchial epithelial
cells were found to be more sensitive to the effects of DEP
with respect to induction of cytokine release and inhibi-
tion of ciliary beat activity (36). Together, these observa-
tions could account for the involvement of environmental
pollutants in asthma exacerbations and provide a link to
the rising trends in asthma observed over the last few de-
cades.
Increased apoptosis has also been reported to occur in
keratinocytes of subjects with atopic dermatitis (12), sug-
gesting that epithelial susceptibility to apoptosis may con-
tribute to the organ-specific expression of some allergic
diseases. Because atopic dermatitis is a condition that pre-
disposes to severe asthma, it is possible that skin and air-
way epithelial cells may express common susceptibility
genes in addition to those for atopy. These considerations
have important implications for our understanding of asthma
pathogenesis and treatment and wider implications for
mechanisms of allergic diseases.
Apoptotic mechanisms play a key role following tissue
injury by enabling disposal of a dying cell without induc-
tion of a proinflammatory response, as occurs after necro-
sis. One of these disposal mechanisms involves the recog-
nition of phosphatidylserine on the outer leaflet of the
plasma membrane by specific receptors on macrophages.
Recognition and engulfment of the apoptotic cell leads to
increased expression and release of TGF- by the mac-
rophages (37) to limit further inflammation. Because TGF-
has been found to decrease expression of Cu,Zn-SOD in
rat hepatocytes (38), this may contribute to the low levels
of this enzyme found in bronchial epithelial cells (32). Fur-
thermore, as TGF- is also a profibrogenic mediator, high
levels of epithelial apoptosis may be responsible for con-
tributing to subepithelial fibrosis, a characteristic feature
of the remodeled airways in asthma (7). Whether subepi-
thelial myofibroblasts also contribute to ongoing epithelial
apoptosis, as has been demonstrated in pulmonary fibrosis
(11), remains to be determined. Such interactions between
epithelial cells and immune cells and/or fibroblasts illus-
trate the complexity of the tissue microenvironment and
its potential to influence disease phenotype.
In conclusion, we have provided evidence for increased
apoptosis in the bronchial epithelium in asthma and, by
using primary cultures, have shown an increase in the sus-
ceptibility of the asthmatic bronchial epithelium to the ef-
fects of oxidants. In being preserved through several genera-
tions in vitro, this susceptibility is unlikely to be due to the
effects of airway inflammation and may help to explain
gene and environment interactions in asthma. The avail-
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ability of a reliable method for the growth of primary cul-
tures from normal and asthmatic bronchial epithelium
should now pave the way toward dissection of the underly-
ing mechanisms that control the altered susceptibility and
function of the epithelium in asthma.
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